Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC Add-on for Antipsychotic Tapering in Remitted Psychosis
NCT06546475Phase 4Not yet recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2024
- Primary completion
- Jul 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of acetylcysteine in psychosis, schizophrenia, sponsored by National Taiwan University Hospital. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
psychosisschizophrenia
Beyond the preview
Go deeper on NCT06546475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06546475.